Approval · Notice of Compliance 16660 · 2015
SOMAVERT: Notice of Compliance 16660
Issued March 6, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16660
- Date
- March 6, 2015
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Growth hormone receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOMAVERT | Not yet assigned | — |
Medicinal ingredients
- PEGVISOMANT 10 MG per VIAL
- PEGVISOMANT 15 MG per VIAL
- PEGVISOMANT 20 MG per VIAL